Kinetic Modeling of 3′-Deoxy-3′-18F-Fluorothymidine for Quantitative Cell Proliferation Imaging in Subcutaneous Tumor Models in Mice
Authors:
- Jae Sung LeeJLJae Sung Lee
- Ki Chum ImKIKi Chum Im
- Seog-Young KimSKSeog-Young Kim
- Soo-Ah ParkSPSoo-Ah Park
- Seung Jin LeeSLSeung Jin Lee
- Seung Jun OhSOSeung Jun Oh
- Dong Soo LeeDLDong Soo Lee
- Dae Hyuk MoonDMDae Hyuk Moon
- 7 November 2008
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 49 (12) , 2057-2066
Abstract
3′-Deoxy-3′-18F-fluorothymidine (18F-FLT) is a thymidine analog that was developed for measuring tumor proliferation with PET. The aim of this study was to establish a kinetic modeling analysis method for quantitative 18F-FLT PET studies in subcutaneous tumor models in mice. Methods: To explore the validity of an image-derived left ventricular input function, we measured equilibrium constants for plasma and whole blood and metabolite fractions in blood after 18F-FLT injection. In parallel, dynamic 18F-FLT PET scans were acquired in 24 mice with a small-animal dedicated PET scanner to compare arterial blood activities obtained by PET and blood sampling. We then investigated kinetic models for 18F-FLT in human epithelial carcinoma (A431) and Lewis lung carcinoma tumor models in mice. Three-compartment models with reversible phosphorylation (k4 ≠ 0, 3C5P) and irreversible phosphorylation (k4 = 0, 3C4P) and a 2-compartment model (2C3P) were examined. The Akaike information criterion and F statistics were used to select the best model for the dataset. Gjedde–Patlak graphic analysis was performed, and standardized uptake values in the last frame were calculated for comparison purposes. In addition, quantitative PET parameters were compared with Ki-67 immunostaining results. Results: 18F-FLT equilibrated rapidly (within 30 s) between plasma and whole blood, and metabolite fractions were negligible during PET scans. A high correlation between arterial blood sampling and PET data was observed. For 120-min dynamic PET data, the 3C5P model best described tissue time–activity curves for tumor regions. The net influx of 18F-FLT (KFLT) and k3 obtained with this model showed reasonable intersubject variability and discrimination ability for tumor models with different proliferation properties. The KFLT obtained from the 60- or 90-min data correlated well with that obtained from the 120-min data as well as with the Ki-67 results. Conclusion: The image-derived arterial input function was found to be feasible for kinetic modeling studies of 18F-FLT PET in mice, and kinetic modeling analysis with an adequate compartment model provided reliable kinetic parameters for measuring tumor proliferation.Keywords
This publication has 20 references indexed in Scilit:
- Antitumor and Antivascular Effects of AVE8062 in Ovarian CarcinomaCancer Research, 2007
- FDG-PET for Pharmacodynamic Assessment of the Fatty Acid Synthase Inhibitor C75 in an Experimental Model of Lung CancerPharmaceutical Research, 2007
- 18F-fluorothymidine kinetics of malignant brain tumorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Use of 3′-deoxy-3′-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical MethodsCancer Research, 2005
- Small Animal Imaging in Drug DevelopmentCurrent Pharmaceutical Design, 2005
- [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Comparison of methodologies for the in vivo assessment of 18 FLT utilisation in colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Dedicated Small Animal Scanners: A New Tool for Drug Development?Current Pharmaceutical Design, 2002
- Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivoNuclear Medicine and Biology, 2000